Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Ariel Dora Stern"'
Autor:
Jelena Schmidt, Nienke M. Schutte, Stefan Buttigieg, David Novillo-Ortiz, Eric Sutherland, Michael Anderson, Bart de Witte, Michael Peolsson, Brigid Unim, Milena Pavlova, Ariel Dora Stern, Elias Mossialos, Robin van Kessel
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-9 (2024)
Abstract Regulatory frameworks for artificial intelligence (AI) are needed to mitigate risks while ensuring the ethical, secure, and effective implementation of AI technology in healthcare and population health. In this article, we present a synthesi
Externí odkaz:
https://doaj.org/article/87895b1e286c4a4cb598132e36fb1474
Autor:
Robin van Kessel, Divya Srivastava, Ilias Kyriopoulos, Giovanni Monti, David Novillo-Ortiz, Ran Milman, Wojciech Wilhelm Zhang-Czabanowski, Greta Nasi, Ariel Dora Stern, George Wharton, Elias Mossialos
Publikováno v:
JMIR mHealth and uHealth, Vol 11, p e49003 (2023)
BackgroundThe adoption of digital health care within health systems is determined by various factors, including pricing and reimbursement. The reimbursement landscape for digital health in Europe remains underresearched. Although various emergency re
Externí odkaz:
https://doaj.org/article/4aa25d82c1d0493fb89bade1db838f7c
Publikováno v:
JMIR Formative Research, Vol 7, p e45713 (2023)
BackgroundThe use of digital health measurement tools has grown substantially in recent years. However, there are concerns that the promised benefits from these products will not be shared equitably. Underserved populations, such as those with lower
Externí odkaz:
https://doaj.org/article/207e0b24cd31412f9802b61b82b8b671
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Objectives In an effort to mitigate COVID-19 related challenges for clinical research, the US Food and Drug Administration (FDA) issued new guidance for the conduct of ‘virtual’ clinical trials in late March 2020. This study documents trends in t
Externí odkaz:
https://doaj.org/article/9d356d685bd9432dba9748075f954396
Publikováno v:
Sensors, Vol 21, Iss 14, p 4937 (2021)
In the area of cardiac monitoring, the use of digitally driven technologies is on the rise. While the development of medical products is advancing rapidly, allowing for new use-cases in cardiac monitoring and other areas, regulatory and legal require
Externí odkaz:
https://doaj.org/article/0984af2826ad4c589d0c695f3ecfe5ff
Publikováno v:
BMJ Open, Vol 9, Iss 6 (2019)
ObjectivesTo more clearly define the landscape of digital medical devices subject to US Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of softwar
Externí odkaz:
https://doaj.org/article/da0dcbf795af484c8c4c122f9fcf5c43
Publikováno v:
JMIR Formative Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd0698c3b086287d6aee668c3322e7db
https://doi.org/10.2196/45713
https://doi.org/10.2196/45713
BACKGROUND The use of digital health measurement tools has grown substantially in recent years, and demand for these products is expected to grow further. However, there are concerns that the promised benefits from digital health products will not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5b70af53b75495f364e519f5bfdb9ae
https://doi.org/10.2196/preprints.45713
https://doi.org/10.2196/preprints.45713
Autor:
Zeid El-Kilani, Jacqueline L. Chen, Ernst R. Berndt, Mark R. Trusheim, Ariel Dora Stern, Amber Jessup, Melissa Ouellet
Publikováno v:
Health Affairs. 40:989-999
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the US and worldwide. Against this backdrop, many look to the expanding market for biosimilars—foll...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::762d1a5bf84b209edbe679327ee5b57d
https://doi.org/10.1377/hlthaff.2020.02239
https://doi.org/10.1377/hlthaff.2020.02239